Arcadia Biosciences (FRA:17D) Institutional Ownership: 0.87% (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:17D Arcadia Biosciences Inc FRA:17D
43 GF Score
Price €3.72
GF Value €15.09
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences Institutional Ownership?

Arcadia Biosciences FRA:17D 43 Institutional Ownership is 0.87% as of Aug. 14, 2026. GuruFocus rates FRA:17D with a GF Score™ of 43/100 and a GF Value™ of €15.09. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Arcadia Biosciences's institutional ownership is 0.87%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Arcadia Biosciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Arcadia Biosciences's Float Percentage Of Total Shares Outstanding is 99.92%.

Arcadia Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Arcadia Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences Institutional Ownership Chart

Arcadia Biosciences Historical Data

The historical data trend for Arcadia Biosciences can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 1.17 1.00 1.00 0.79 1.00 1.69 1.68 2.51 1.38 0.87
FRA:17D
43GF Score
Arcadia Biosciences Inc FRA:17D
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcadia Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.87% mean?
Arcadia Biosciences (FRA:17D) has a Institutional Ownership of 0.87% as of Aug. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Arcadia Biosciences and its competitors.
Is Arcadia Biosciences' Institutional Ownership too high?
Arcadia Biosciences' current Institutional Ownership is 0.87%. Overall, Arcadia Biosciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Institutional Ownership compare to ORISF and ARRT?
Arcadia Biosciences' Institutional Ownership of 0.87% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Consumer Packaged Goods company?
A good Institutional Ownership depends on the Consumer Packaged Goods industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Arcadia Biosciences and its competitors. Arcadia Biosciences's current Institutional Ownership is 0.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Arcadia Biosciences (FRA:17D) has a current Institutional Ownership of 0.87%. The stock's GF Value™ is €15.09, compared to a current price of €3.72 — trading 75.3% below its estimated fair value. The current Institutional Ownership is 0.87%. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Arcadia Biosciences (FRA:17D), the current Institutional Ownership is 0.87% as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcadia Biosciences (FRA:17D) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of €3.72 is trading 75.3% below its estimated GF Value™ of €15.09.

Key valuation signals for FRA:17D:

  • Institutional Ownership: 0.87%
  • GF Value™: €15.09 vs. price of €3.72 (75.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:17D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcadia Biosciences Business Description

Other Exchanges RKDA:USA
Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score

Get the complete analysis for FRA:17D

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€15.09
GF Value